Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy

NCT01092481 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
1580
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Samsung Medical Center